SANGAMIND evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-30T14:01:26.950260+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 32345300000.0
- net_income
- 826000000.0
- operating_cash_flow
- 2687200000.0
- free_cash_flow
- 430700000.0
- total_assets
- 33148200000.0
- total_liabilities
- 22385500000.0
- total_equity
- 10762700000.0
- cash
- 508900000.0
- total_debt
- 12779500000.0
- revenue_growth
- 0.13216192092966272
- earnings_growth
- 1.5974842767295598
- net_margin
- 0.02553694045193583
- roe
- 0.07674654129539986
- debt_to_equity
- 1.187387923104797
- cash_conversion
- 3.2532687651331718
- free_cash_flow_margin
- 0.013315690378509397
- trailing_pe
- 26.18
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-5685b06ebf9748576eea981360b86581c627ef45a3c72e1aecef9132792e7634
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 32670c1473bf4ee09e68efe7990ebe9bab4d8aa7f7e6f825e988cd11193cca38
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 4bca1d3b5cae2bcee4e0ecbe4767719630e1ab68b5b31219d66b5705a162b361
- daily-price: 1f5a0dde1dfe2c8b56b2260605243b8de750013124bac0a5d9d7a8a406fd554a
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 634.55.
- The trailing 5-session price return was 9.46%.
- The trailing 20-session price return was 11.36%.
- The trailing 60-session price return was 15.66%.
- The trailing 250-session price return was 45.95%.
- Average cached traded value over twenty sessions was INR 31,086,570.
- The closing price was -1.70% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-30T14:01:26.950260+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.13216192092966272.
- The cached financial metric net margin is 0.02553694045193583.
- The cached financial metric roe is 0.07674654129539986.
- The cached financial metric debt to equity is 1.187387923104797.
- The cached financial metric cash conversion is 3.2532687651331718.
- The cached financial metric free cash flow margin is 0.013315690378509397.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.